Moderna (MRNA) Asset Utilization Ratio (2019 - 2026)

Moderna (MRNA) has reported Asset Utilization Ratio for 8 consecutive years, with 0.2 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio fell 20.31% year-over-year to 0.2 in Q2 2026; TTM through Jun 2026 was 0.2, a 20.31% decrease from a year earlier, with the FY2025 full-year figure at 0.15, down 26.11% from the prior year.
• Asset Utilization Ratio was 0.2 for Q2 2026 at Moderna, up from 0.19 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.86 in Q1 2022 and troughed at 0.16 in Q4 2025.
• A 5-year average of 0.42 and a median of 0.32 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio jumped 216.97% in 2022 and sank 51.35% in 2024, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.74 in 2022, then plunged by 51.27% to 0.36 in 2023, then sank by 40.23% to 0.22 in 2024, then declined by 26.49% to 0.16 in 2025, then increased by 24.94% to 0.2 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.2 (Q2 2026), 0.19 (Q1 2026), and 0.16 (Q4 2025), per Business Quant data.